ME 23ANDME HLDG CO

23andMe Introduces New Feature Helping African Americans Trace Their Roots to Post Slavery Communities in the South

23andMe Introduces New Feature Helping African Americans Trace Their Roots to Post Slavery Communities in the South

The new African American Genetic Groups feature traces customers' ancestral connections from before the early-to-mid-20th century migrations to more than 200 communities in Southern states

SUNNYVALE, Calif., Oct. 17, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics company, released a powerful new feature that enables African American customers to trace their roots to over 200 communities of people of African descent in the Southern United States. These communities include those with connections to the Piney Woods region in the dense forests and rolling hills in rural Mississippi; the creoles of the River Parishes and Greater New Orleans who draw on a unique mix of French, Spanish, Native American and African cultures; and the Gullah Geechee of South Carolina and Georgia, among many others.

Many Americans do not realize that before the Great Migration, more than 90 percent of the Black community lived in the South. Then, during the two waves of the Great Migration between 1910 and 1970, roughly six million Black Americans left their homes in primarily rural southern communities, moving north and west in search of economic opportunities, and to escape poverty, repression, and racial violence.

“History is written in our DNA, and it’s important for African Americans to see how their family histories are woven so deeply into the history of the United States,” said Steven Micheletti, Ph.D., 23andMe Senior Scientist, Population Genetics, and lead on the 23andMe African American Genetics Group feature.

“Many African American families whose ancestors fled the South during the Great Migration kept some connection to those communities that they left behind, but over the decades, some families lost those connections. Learning this information could help reconnect families to these communities.”

The new African American Genetic Groups feature offers families and individuals direct links to the places where their ancestors once lived, providing meaningful insights into African American history and heritage within the United States. These communities offer a window into the unique histories, cultures, and traditions passed down over time. The new feature will include shared ancestral locations, a list of common maternal and paternal haplogroups, and additional information to help those tracing their connections to these communities.

23andMe customers will be able to trace connections to the following African American Genetic Groups, among many others:

  • Southern Mississippi Pines African Americans
  • Yazoo River Basin Mississippi African Americans
  • Georgia Coastal Plain African Americans
  • Central Carolinas Piedmont African Americans
  • Central Georgia Piedmont African Americans
  • Central Kentucky African Americans
  • Chesapeake Bay African Americans
  • Savannah River Basin African Americans
  • Lower Alabama African Americans
  • Maryland Western Shore African Americans

(For a full list, please see our ).

For many African American families, tracing their roots can be challenging due to the disruptions caused by the transatlantic slave trade, systemic racism, and displacement during the Great Migration. That massive movement of people transformed the political, cultural, and social landscape in the United States. Families moved along well-worn paths to cities like Chicago, New York, Los Angeles, and Detroit, forever changing the fabric of these urban centers.

Approximately 88 percent of 23andMe customers who self-identify as African American will see connections to at least one of the newly identified African American Genetic Groups. For 23andMe+ Premium™ customers, who have access to more distant connections, this number rises to 95 percent.

About 5 percent of 23andMe customers who identify as white or caucasian and have some African ancestry will also receive matches. Whereas many African Americans are well aware of their mixed ancestry that often includes European ancestry, many people who self-identify as white but have some may not know that same history.

This important new feature is part of a broader effort to improve representation in 23andMe’s product and within its research. For over a decade, 23andMe has taken steps to enhance the diversity of its research dating back to its , and its African .

Most recently, 23andMe collaborated with researchers at the National Institutes of Health and Johns Hopkins University School of Medicine to publish the , linking the trait to increased risk for certain blood clots. In 2023, scientists from 23andMe, Harvard, and the Smithsonian  who labored at a Maryland iron furnace and established genetic connections between them and 40,000 of their living relatives. 23andMe’s new  feature now allows customers to see if they share a connection to these historical individuals.

Contact Information

About 23andMe

23andMe is a genetics-led consumer healthcare and therapeutics company empowering a healthier future. For more information, please visit investors.23andme.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including. All statements, other than statements of historical fact, included or incorporated in this press release are forward-looking statements. The words "believes," "anticipates," "estimates," "plans," "expects," "intends," "may," "could," "should," "potential," "likely," "projects," “predicts,” "continue," "will," “schedule,” and "would" or, in each case, their negative or other variations or comparable terminology, are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are predictions based on 23andMe’s current expectations and projections about future events and various assumptions. 23andMe cannot guarantee that it will actually achieve the plans, intentions, or expectations disclosed in its forward-looking statements and you should not place undue reliance on 23andMe’s forward-looking statements. These forward-looking statements involve a number of risks, uncertainties (many of which are beyond the control of 23andMe), or other assumptions that may cause actual results or performance to differ materially from those expressed or implied by these forward-looking statements. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the Company’s filings with the Securities and Exchange Commission, including under Item 1A, “Risk Factors” in the Company’s most recent Annual Report on Form 10-K, as filed with the Securities and Exchange Commission, and as revised and updated by our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The statements made herein are made as of the date of this press release and, except as may be required by law, 23andMe undertakes no obligation to update them, whether as a result of new information, developments, or otherwise.



EN
17/10/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on 23ANDME HLDG CO

 PRESS RELEASE

23andMe Provides Update Regarding Court-Supervised Sale Process

23andMe Provides Update Regarding Court-Supervised Sale Process SAN FRANCISCO, April 18, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a leading human genetics and biotechnology company, today provided additional information on the protections in place for customer data in connection with the court-supervised sale of the Company’s assets. The process is being led by the Special Committee of the Company’s Board of Directors, which will evaluate potential acquisition bids, and supervised by the U.S. Bankruptcy Court for the Eastern District of Misso...

 PRESS RELEASE

23andMe Confirms All Potential Buyers Must Agree to Comply With Privac...

23andMe Confirms All Potential Buyers Must Agree to Comply With Privacy Policy and Applicable Law Receives Court Approval for First Day Motions to Support Ongoing Business Operations SAN FRANCISCO, March 26, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (Nasdaq: ME), a leading human genetics and biotechnology company, today announced that it has received approvals from the U.S. Bankruptcy Court for the Eastern District of Missouri (the “Court”) for its “first day” motions related to 23andMe’s voluntary Chapter 11 petitions filed March 23, 2025, including auth...

Pierre FerraguÊ
  • Pierre FerraguÊ

The Tech Infrastructure Quarterly Bible 4Q24

We publish today our comprehensive quarterly bible: 240 pages of detailed analyses on what happened in the last 3 months, and how we interpret it, in light of our current convictions. The first section acts as a PM summary, outlining our key findings, and latest thoughts on the semi cycle, in 6 slides.

 PRESS RELEASE

23andMe Initiates Voluntary Chapter 11 Process to Maximize Stakeholder...

23andMe Initiates Voluntary Chapter 11 Process to Maximize Stakeholder Value Through Court-Supervised Sale Process Intends to use Proceedings to Conduct a Value-Maximizing Sale Process and Resolve Liabilities Company Expects to Continue Business Operations in the Ordinary Course During Proceedings; Secures Commitment for Approximately $35 Million in DIP Financing to Support Ongoing Operations No Changes to Customer Data Management and Access; Company Remains Committed to Transparency Around Customer Data Privacy; Any Buyer will be Required to Comply with Applicable Law with Respect to Tre...

 PRESS RELEASE

23andMe Launches New Homocysteine (MTHFR-Related) Genetic Report and A...

23andMe Launches New Homocysteine (MTHFR-Related) Genetic Report and Accompanying Lab Test Provides 23andMe+ Premium members with highly requested insight into their likelihood of developing slightly elevated homocysteine levels SAN FRANCISCO, March 21, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics company with a mission to help people access, understand, and benefit from the human genome, today released a new report on the genetics of homocysteine levels for 23andMe+ Premium members, as well as a blood test for next steps in further understanding s...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch